XML 29 R1.htm IDEA: XBRL DOCUMENT v3.23.3
Document and Entity Information - USD ($)
$ / shares in Units, $ in Millions
 12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2021
Sep. 20, 2023
Dec. 30, 2022
Cover [Abstract]          
Entity Central Index Key 0001385818        
Document Type 10-K        
Document Annual Report true        
Document Period End Date Jun. 30, 2023        
Document Transition Report false        
Entity File Number 001-38247        
Entity Registrant Name AYTU BIOPHARMA, INC.        
Entity Incorporation, State or Country Code DE        
Entity Tax Identification Number 47-0883144        
Entity Address, Address Line One 7900 East Union Avenue        
Entity Address, Address Line Two Suite 920        
Entity Address, City or Town Denver        
Entity Address, State or Province CO        
Entity Address, Postal Zip Code 80237        
City Area Code 720        
Local Phone Number 437-6580        
Title of 12(b) Security Common Stock, par value $0.0001 per share        
Entity Listing, Par Value Per Share $ 0.0001        
Trading Symbol AYTU        
Security Exchange Name NASDAQ        
Entity Well-known Seasoned Issuer No        
Entity Voluntary Filers No        
Entity Current Reporting Status Yes        
Entity Interactive Data Current Yes        
Entity Filer Category Non-accelerated Filer        
Entity Small Business true        
Entity Emerging Growth Company false        
ICFR Auditor Attestation Flag false        
Entity Shell Company false        
Entity Public Float         $ 12.3
Entity Common Stock, Shares Outstanding       5,530,027  
Current Fiscal Year End Date --06-30        
Document Fiscal Year Focus 2023        
Document Fiscal Period Focus FY        
Amendment Flag false        
Auditor Name Grant Thornton, LLP Plante & Moran, PLLC Plante & Moran, PLLC    
Auditor Firm ID 248 166 166    
Auditor Location Denver, Colorado Denver, Colorado Denver, Colorado